LGT Group Foundation’s Zimmer Biomet ZBH Stock Holding History

LGT Group Foundation’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,127	Closed	-$259K	–	280
2023 Q4	$259K	Hold	2,127	–	–	0.01%	234
2023 Q3	$237K	Buy	+2,127	New	+$270K	0.01%	242

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LGT Group Foundation's ZBH Position: Q1 2024 in Review

LGT Group Foundation sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 2,127 shares — an estimated $259K sold.

LGT Group Foundation first reported a position in ZBH in Q3 2023 and held it in 2 quarters. The position peaked at $259K in Q4 2023. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

LGT Group Foundation reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
LGT Group Foundation sold 2,127 Zimmer Biomet shares in Q1 2024, an estimated $259K.
LGT Group Foundation first reported a position in Zimmer Biomet in Q3 2023 and held it in 2 quarters.
LGT Group Foundation's Zimmer Biomet position peaked at $259K in Q4 2023.
1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on LGT Group Foundation's 13F filing for Q1 2024, filed 14 May 2024.